Detalhe da pesquisa
1.
Tumor-specific activation of folate receptor beta enables reprogramming of immune cells in the tumor microenvironment.
Front Immunol
; 15: 1354735, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38384467
2.
Biological evaluation of novel side chain containing CQTrICh-analogs as antimalarials and their development as PfCDPK1 kinase inhibitors.
Heliyon
; 10(3): e25077, 2024 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38327451
3.
Selective reprogramming of regulatory T cells in solid tumors can strongly enhance or inhibit tumor growth.
Front Immunol
; 14: 1274199, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37928524
4.
Targeted Rejuvenation of Exhausted Chimeric Antigen Receptor T Cells Regresses Refractory Solid Tumors.
Mol Cancer Res
; 20(5): 823-833, 2022 05 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35135862
5.
Repolarization of Tumor-Infiltrating Myeloid Cells for Augmentation of CAR T Cell Therapies.
Front Immunol
; 13: 816761, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35250995
6.
Efficient capture of circulating tumor cells with low molecular weight folate receptor-specific ligands.
Sci Rep
; 12(1): 8555, 2022 05 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35595733
7.
Structure activity relationship (SAR) study identifies a quinoxaline urea analog that modulates IKKß phosphorylation for pancreatic cancer therapy.
Eur J Med Chem
; 222: 113579, 2021 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34098465
8.
Small molecule binding to inhibitor of nuclear factor kappa-B kinase subunit beta in an ATP non-competitive manner.
Chem Commun (Camb)
; 57(38): 4678-4681, 2021 May 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33977973